View in EDS HTML Full Text PDF Full Text

Risankizumab treatment in psoriasis patients who failed anti‐IL17: A 52‐week real‐life study.

Saved in:
Bibliographic Details
Title: Risankizumab treatment in psoriasis patients who failed anti‐IL17: A 52‐week real‐life study.
Authors: Megna, Matteo1 (AUTHOR) mat24@libero.it, Potestio, Luca1 (AUTHOR), Ruggiero, Angelo1 (AUTHOR), Camela, Elisa1 (AUTHOR), Fabbrocini, Gabriella1 (AUTHOR)
Source: Dermatologic Therapy. Jul2022, Vol. 35 Issue 7, p1-7. 7p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:13960296
DOI:10.1111/dth.15524